Latest News

Sex Influences DAPT De-escalation Outcomes Post-PCI
Written by: Interventional Cardiology
Sex Influences DAPT De-escalation Outcomes Post-PCI
Tirzepatide Linked to Lower Cardiorenal Events vs Dulaglutide
Written by: Radcliffe CKM
Tirzepatide Linked to Lower Cardiorenal Events vs Dulaglutide
Finerenone Approved in EU for HF with LVEF ≥40%
Written by: Heart Failure Academy
Finerenone Approved in EU for HF with LVEF ≥40%
SOUL: Oral Semaglutide Improves CV Risk Factors in T2D
Written by: Radcliffe CKM
SOUL: Oral Semaglutide Improves CV Risk Factors in T2D
Ez-PAVE: Lower LDL-C Target Reduces CV Events
Written by: Radcliffe CVRM
Ez-PAVE: Lower LDL-C Target Reduces CV Events
LBBAP Not Non-Inferior to BiVP for CRT in LBBB Patients
Written by: Arrhythmia and Electrophysiology Review
LBBAP Not Non-Inferior to BiVP for CRT in LBBB Patients
PFA for Atrial Flutter: ADVANTAGE AF Substudy Results
Written by: Arrhythmia Academy
PFA for Atrial Flutter: ADVANTAGE AF Substudy Results
hsCRP Improves CV Risk Prediction in Primary Prevention
Written by: Radcliffe CVRM
hsCRP Improves CV Risk Prediction in Primary Prevention
Smartwatch Screening Boosts AF Detection in High-Risk Patients
Written by: Arrhythmia Academy
Smartwatch Screening Boosts AF Detection in High-Risk Patients
Smartwatch Data Predicts Heart Failure Exacerbations
Written by: CFR Journal
Smartwatch Data Predicts Heart Failure Exacerbations

External news

Written by: Cardiovascular Business
Medline recalls nearly 50K procedure kits, including many used by cardiologists
Written by: Medscape
ECG Challenge: Out of Sync After ICD Surgery
Written by: Cardiovascular Business
Looking ahead to the future of FFR-CT
Written by: Cardiovascular Business
Medtronic completes $550M acquisition of neurovascular company
Written by: Medscape
Which Factors Affect Heart Health in Indigenous Canadians?
Written by: Cardiac Vascular News
Cardiawave Announces First Routine Treatments Performed with Valvosoft® Following CE Mark Approval and Accelerates Its Deployment
Written by: Cardiac Vascular News
Caristo Diagnostics Selected by World Economic Forum as a 2026 Technology Pioneer
Written by: Cardiac Vascular News
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
Written by: Cardiac Vascular News
TAVR Changed Valve Replacement; Anteris Says Longer-Living Patients Expose the Next Challenge
Written by: Cardiac Vascular News
Humacyte’s Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting